OVARIAN CANCER WORKSHOP
Workshop Overview
Ovarian cancer is an important women's health concern that requires greater public awareness, timely clinical evaluation and access to appropriate diagnostic and treatment services. Because its early symptoms may be vague or easily mistaken for common digestive or urinary problems, awareness among women, healthcare professionals and communities is particularly important.
BioGenesis Health Cluster proposes to organise an Ovarian Cancer Awareness and Clinical Demonstration Workshop as part of the 8th Global Cancer Summit 2027 in Aizawl, Mizoram.
The workshop will be led by an experienced gynaecologist, gynaecological oncologist, clinician or cancer scientist. It will combine expert presentations, anatomical demonstrations, scientific discussions and an interactive question-and-answer session.
The programme will bring together clinicians, surgeons, oncologists, researchers, medical students, healthcare workers, NGOs and members of the general public to improve understanding of ovarian cancer symptoms, risk factors, clinical assessment, diagnostic procedures, treatment approaches and current research developments.
With a special focus on women's health and the healthcare needs of Northeast India, the workshop aims to strengthen cancer awareness, encourage timely medical consultation and promote collaboration among healthcare institutions, research organisations and community groups.
Scientific programme and demonstrations
Session 1 - Understanding Ovarian Cancer
Introduction to ovarian anatomy, different types of ovarian cancer, relevant risk factors, family history and hereditary cancer syndromes.
Session 2 - Symptoms and Clinical Demonstration
An expert-led demonstration using anatomical models to explain ovarian anatomy and the clinical assessment process. Discuss persistent abdominal bloating, pelvic or abdominal pain, feeling full quickly, difficulty eating and changes in urinary habits.
Session 3 - Diagnostic Evaluation
Explain clinical history, physical examination, pelvic ultrasound, selected blood tests such as CA-125, and the role of specialist assessment. Clarify that no single test is suitable for screening every woman without symptoms.
Session 4 - Scientific Research and Advances
Discussion of ovarian tumour biology, pathology, genetic testing, BRCA-related risk, molecular research and developments in targeted treatment.
Session 5 - Treatment and Comprehensive Care
An overview of specialist surgery, chemotherapy, selected targeted therapies, genetic counselling, supportive care and multidisciplinary treatment planning.
Session 6 - Public Awareness and Expert Interaction
An open discussion on recognising persistent symptoms, understanding family history, overcoming misconceptions and finding appropriate medical services.
Target participants
- Clinicians, gynaecologists and oncologists
- Clinical assessment, referral pathways, diagnosis and evidence-based treatment.
- Scientists and research scholars
- Ovarian cancer biology, genetics, biomarkers and translational research.
- Medical students and healthcare workers
- Women's health education, symptom recognition and patient communication.
- Women, NGOs and the general public
- Awareness of persistent symptoms, family history and the importance of timely medical evaluation.
Expected learning outcomes
- Improved awareness of ovarian cancer symptoms and relevant risk factors.
- Better understanding of clinical assessment and diagnostic procedures.
- Greater knowledge of hereditary risk and the role of genetic counselling.
- Improved communication between researchers, healthcare professionals and communities.
- Stronger institutional collaboration to promote women's cancer awareness in Northeast India.
- Increased public understanding of appropriate referral and treatment pathways.
Suggested workshop arrangements
| Component |
Recommended format |
| Duration |
2-3 hours |
| Lead faculty |
Experienced gynaecological oncologist, gynaecologist or cancer scientist |
| Demonstration |
Anatomical pelvic model, diagrams and diagnostic case examples |
| Scientific discussion |
Clinicians, pathologists, researchers and oncology specialists |
| Public interaction |
Questions and answers, myth clarification and awareness education |
| Supporting material |
Illustrated educational handouts and referral information |
The demonstration should focus on educational models, diagrams and appropriately anonymised case examples. Any patient-based demonstration must have informed consent and appropriate privacy safeguards.